Europska Unija - hrvatski - EMA (European Medicines Agency)

yes pharmaceutical development services gmbh - doksorubicin hidroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

Europska Unija - hrvatski - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastična sredstva - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Europska Unija - hrvatski - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - ophthalmologicals - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

splendor d.o.o. majstorska 3 10000 zagreb -

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

johnson & johnson s.e. d.o.o., zagreb - ublažavanje stanja umornog i iritiranog oka, vlaženje oka ili obnavljanje prirodnog suznog filma

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sanyko d.o.o. banjavčićeva 11 10000 zagreb -

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

nutra essential otc s.l., calle de la granja, 1, alcobendas-madrid, Španjolska - ibuprofen - oralna suspenzija - 20 mg/ ml - urbroj: jedan mililitar oralne suspenzije sadrži 20 mg ibuprofena

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - ibuprofen - oralna suspenzija - 20 mg/ml - urbroj: 1 ml oralne suspenzije sadrži 20 mg ibuprofena

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - ibuprofen - oralna suspenzija - 40 mg/ml - urbroj: 1 ml oralne suspenzije sadrži 40 mg ibuprofena

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

berlin-chemie ag, glienicker weg 125, berlin, njemačka - ibuprofen - oralna suspenzija - 20 mg/ml - urbroj: svaki ml oralne suspenzije sadrži 20 mg ibuprofena